The structure and function of the novel MHC class II molecule, HLA-DM.
Gruneberg
U
U
Human Immunogenetics Group, Imperial Cancer Research Fund, London, UK.
Van Ham
S M
SM
Malcherek
G
G
Broker
I
I
Melms
A
A
Trowsdale
J
J
D000944:Antigens, Differentiation, B-Lymphocyte / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D019281:Dimerization; D005802:Genes, MHC Class II; D006681:HLA-D Antigens / Q000737:chemistry* / Q000302:isolation & purification / Q000502:physiology*; D000949:Histocompatibility Antigens Class II / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification
D000944:Antigens, Differentiation, B-Lymphocyte; C416189:H2-M antigens; D006681:HLA-D Antigens; C084245:HLA-DM antigens; D000949:Histocompatibility Antigens Class II; D011994:Recombinant Proteins; C045084:invariant chain